Sysmex is using a new product supply scheme to accelerate business expansion in China

With the economy growing rapidly, China is simultaneously introducing healthcare system reforms, including a classification diagnosis system, and putting a healthcare environment in place. As such, demand for testing is increasing. Sysmex was quick to recognize the growth potential of the Chinese market. To date, they have established a reagent factory in the country, and have agreements in place with more than 200 sales distributors, through which they provide products with made-in-Japan quality throughout China. The company has also established structures for supplying reagents and services, and is expanding business in the country. Currently, China accounts for approximately one-fourth of Sysmex’s consolidated net sales. Sysmex is launching the XS-500ix, a new product in the automated hematology analyzer XS-series, for the China market. The primary target of the XS-500ix, which is designed for high performance, compactness, and the ability to measure minute quantities of blood, is small and medium-sized medical institutions classified as tier II or lower – a category in which the number of hospitals and the patients they serve is expected to expand. The XS-500ix makes use of a product supply scheme that matches market characteristics. Under this scheme, for the first time Sysmex will employ the knockdown production method.

The main components for this product will be processed and manufactured at the Kakogawa Factory (Kakogawa, Hyogo Prefecture), a factory for compact models. These components will then be shipped to China, where assembly, adjustment, testing, and other manufacturing processes will be handled at the Jinan Factory (Jinan, Shandong Province, China). Adhering to the frameworks for ensuring high levels of quality and productivity that Sysmex has cultivated when manufacturing instruments in Japan, the Jinan Factory will provide high-quality instruments to customers, inspiring confidence. Competition is growing increasingly fierce in the China market. With this product, Sysmex aims to strengthen its sales promotion activities targeting small and medium-sized medical institutions classified as tier II or lower – an area where particularly high levels of market growth are forecast. The company also intends to further increase their market share and expand business in the hematology field.